66 related articles for article (PubMed ID: 8289877)
1. Computer-assisted design of dopamine transporter ligands.
Loew GH; Villar HO; Maguire PA; Davies MF
NIDA Res Monogr; 1993; 134():165-77. PubMed ID: 8289877
[No Abstract] [Full Text] [Related]
2. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
3. TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.
Hoepping A; Reisgys M; Brust P; Seifert S; Spies H; Alberto R; Johannsen B
J Med Chem; 1998 Nov; 41(23):4429-32. PubMed ID: 9804682
[No Abstract] [Full Text] [Related]
4. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
[No Abstract] [Full Text] [Related]
5. Catecholamine reuptake and storage. Overview.
Bönisch H; Eiden L
Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
[No Abstract] [Full Text] [Related]
6. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
[TBL] [Abstract][Full Text] [Related]
7. Center stage for the serotonin transporter: a gain-of-function polymorphism in persons with obsessive-compulsive disorder.
Torres GE; Caron MG
Mol Pharmacol; 2003 Aug; 64(2):196-8. PubMed ID: 12869622
[No Abstract] [Full Text] [Related]
8. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
Pifl C; Giros B; Caron MG
Adv Neurol; 1996; 69():235-8. PubMed ID: 8615133
[No Abstract] [Full Text] [Related]
9. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
Xu C; Reith ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter network and pathways.
Maiya R; Mayfield RD
Int Rev Neurobiol; 2004; 61():79-96. PubMed ID: 15482812
[No Abstract] [Full Text] [Related]
12. The serotonin transporter: a vehicle to elucidate pulmonary hypertension?
Weir EK; Hong Z; Varghese A
Circ Res; 2004 May; 94(9):1152-4. PubMed ID: 15142967
[No Abstract] [Full Text] [Related]
13. Tc-99m-labeled tropanes as dopamine transporter imaging agents.
Meegalla S; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Frederick D; Kung HF
Bioconjug Chem; 1996; 7(4):421-9. PubMed ID: 8853455
[TBL] [Abstract][Full Text] [Related]
14. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter.
Newman AH; Izenwasser S; Robarge MJ; Kline RH
J Med Chem; 1999 Sep; 42(18):3502-9. PubMed ID: 10479283
[TBL] [Abstract][Full Text] [Related]
15. [Aminetransporters].
Shimada S
Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):244-52. PubMed ID: 9162958
[No Abstract] [Full Text] [Related]
16. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives.
Xu L; Kulkarni SS; Izenwasser S; Katz JL; Kopajtic T; Lomenzo SA; Newman AH; Trudell ML
J Med Chem; 2004 Mar; 47(7):1676-82. PubMed ID: 15027858
[TBL] [Abstract][Full Text] [Related]
18. Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
Dutta AK; Coffey LL; Reith ME
J Med Chem; 1997 Jan; 40(1):35-43. PubMed ID: 9016326
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites.
Davies HM; Hopper DW; Hansen T; Liu Q; Childers SR
Bioorg Med Chem Lett; 2004 Apr; 14(7):1799-802. PubMed ID: 15026075
[TBL] [Abstract][Full Text] [Related]
20. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.
Husbands SM; Izenwasser S; Loeloff RJ; Katz JL; Bowen WD; Vilner BJ; Newman AH
J Med Chem; 1997 Dec; 40(26):4340-46. PubMed ID: 9435903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
